Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Stability of Chlamydia trachomatis RNA after long-term biobank storage.

Rose OM, Fredricks DN, Soge OO, Farooq F, Tang G, Ness R, Haggerty CL.

Sex Transm Infect. 2019 Nov;95(7):551. doi: 10.1136/sextrans-2019-054141. No abstract available.

PMID:
31628264
2.

Genital Chlamydia infection in hyperlipidemic mouse models exacerbates atherosclerosis.

Nagarajan UM, Sikes JD, Burris RL, Jha R, Popovic B, Fraungruber P, Hennings L, Haggerty CL, Nagarajan S.

Atherosclerosis. 2019 Sep 27;290:103-110. doi: 10.1016/j.atherosclerosis.2019.09.021. [Epub ahead of print]

PMID:
31604170
3.

Mode of delivery and short-term infant health outcomes: a prospective cohort study in a peri-urban Indian population.

Gondwe T, Betha K, Kusneniwar GN, Bunker CH, Tang G, Simhan H, Reddy PS, Haggerty CL.

BMC Pediatr. 2018 Nov 6;18(1):346. doi: 10.1186/s12887-018-1324-3.

4.

Fetal sexual dimorphism in systemic soluble fms-like tyrosine kinase 1 among normotensive and preeclamptic women.

Taylor BD, Haggerty CL, Ness RB, Hougaard DM, Skogstrand K, Roberts JM, Olsen J.

Am J Reprod Immunol. 2018 Nov;80(5):e13034. doi: 10.1111/aji.13034. Epub 2018 Aug 14.

PMID:
30106204
5.

The impact of female fetal sex on preeclampsia and the maternal immune milieu.

Taylor BD, Ness RB, Klebanoff MA, Tang G, Roberts JM, Hougaard DM, Skogstrand K, Haggerty CL.

Pregnancy Hypertens. 2018 Apr;12:53-57. doi: 10.1016/j.preghy.2018.02.009. Epub 2018 Feb 24.

6.

Toll-like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease.

Taylor BD, Totten PA, Astete SG, Ferris MJ, Martin DH, Ness RB, Haggerty CL.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12804. Epub 2017 Dec 29.

7.

Population-attributable fraction of tubal factor infertility associated with chlamydia.

Gorwitz RJ, Wiesenfeld HC, Chen PL, Hammond KR, Sereday KA, Haggerty CL, Johnson RE, Papp JR, Kissin DM, Henning TC, Hook EW 3rd, Steinkampf MP, Markowitz LE, Geisler WM.

Am J Obstet Gynecol. 2017 Sep;217(3):336.e1-336.e16. doi: 10.1016/j.ajog.2017.05.026. Epub 2017 May 19.

8.

First and second trimester immune biomarkers in preeclamptic and normotensive women.

Taylor BD, Ness RB, Klebanoff MA, Zoh R, Bass D, Hougaard DM, Skogstrand K, Haggerty CL.

Pregnancy Hypertens. 2016 Oct;6(4):388-393. doi: 10.1016/j.preghy.2016.09.002. Epub 2016 Sep 17.

9.

Whole-Exome Sequencing to Identify Novel Biological Pathways Associated With Infertility After Pelvic Inflammatory Disease.

Taylor BD, Zheng X, Darville T, Zhong W, Konganti K, Abiodun-Ojo O, Ness RB, O'Connell CM, Haggerty CL.

Sex Transm Dis. 2017 Jan;44(1):35-41.

10.

Prevalence of Chlamydia trachomatis among Childbearing Age Women in India: A Systematic Review.

Betha K, Robertson JM, Tang G, Haggerty CL.

Infect Dis Obstet Gynecol. 2016;2016:8561645. Epub 2016 Sep 8. Review.

11.

Cohort Profile: The Longitudinal Indian Family hEalth (LIFE) Pilot Study, Telangana State, India.

Kusneniwar GN, Whelan RM, Betha K, Robertson JM, Ramidi PR, Balasubramanian K, Kamasamudram V, Haggerty CL, Bunker CH, Reddy PS.

Int J Epidemiol. 2017 Jun 1;46(3):788-789j. doi: 10.1093/ije/dyw174. No abstract available.

12.

Abusive Experiences and Young Women's Sexual Health Outcomes: Is Condom Negotiation Self-Efficacy a Mediator?

Jones KA, Cornelius MD, Silverman JG, Tancredi DJ, Decker MR, Haggerty CL, De Genna NM, Miller E.

Perspect Sex Reprod Health. 2016 Jun;48(2):57-64. doi: 10.1363/48e8616. Epub 2016 Apr 14.

13.

Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Taylor BD, Tang G, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, Haggerty CL.

Pregnancy Hypertens. 2016 Jan;6(1):72-8. doi: 10.1016/j.preghy.2015.11.002. Epub 2015 Nov 10.

14.

Identification of novel microbes associated with pelvic inflammatory disease and infertility.

Haggerty CL, Totten PA, Tang G, Astete SG, Ferris MJ, Norori J, Bass DC, Martin DH, Taylor BD, Ness RB.

Sex Transm Infect. 2016 Sep;92(6):441-6. doi: 10.1136/sextrans-2015-052285. Epub 2016 Jan 29.

15.

Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women.

Taylor BD, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, Haggerty CL.

Hypertension. 2015 Mar;65(3):594-9. doi: 10.1161/HYPERTENSIONAHA.114.03979. Epub 2014 Dec 15.

16.

Fetal sex and race modify the predictors of fetal growth.

Reynolds SA, Roberts JM, Bodnar LM, Haggerty CL, Youk AO, Catov JM.

Matern Child Health J. 2015 Apr;19(4):798-810. doi: 10.1007/s10995-014-1571-3.

PMID:
25030701
17.

Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African-American women with pelvic inflammatory disease.

Taylor BD, Darville T, Ferrell RE, Ness RB, Kelsey SF, Haggerty CL.

Sex Transm Infect. 2014 Nov;90(7):563-6. doi: 10.1136/sextrans-2014-051524. Epub 2014 May 21.

PMID:
24848367
18.

Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.

Barral R, Desai R, Zheng X, Frazer LC, Sucato GS, Haggerty CL, O'Connell CM, Zurenski MA, Darville T.

J Reprod Immunol. 2014 Jun;103:29-37. doi: 10.1016/j.jri.2014.01.002. Epub 2014 Feb 1.

19.

Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia.

Haggerty CL, Klebanoff MA, Panum I, Uldum SA, Bass DC, Olsen J, Roberts JM, Ness RB.

Pregnancy Hypertens. 2013 Jul 1;3(3):151-154.

20.

Relationship of selected bacterial vaginosis-associated bacteria to Nugent score bacterial vaginosis among urban women early in pregnancy.

Nelson DB, Komaroff E, Nachamkin I, Haggerty CL, Dibble L, Mastrogiannis D, Liu C, Fredricks DN.

Sex Transm Dis. 2013 Sep;40(9):721-3. doi: 10.1097/OLQ.0000000000000001. Erratum in: Sex Transm Dis. 2014 Sep;41(9):570. David, Fredricks N [corrected to Fredricks, David N].

21.

Does bacterial vaginosis cause pelvic inflammatory disease?

Taylor BD, Darville T, Haggerty CL.

Sex Transm Dis. 2013 Feb;40(2):117-22. doi: 10.1097/OLQ.0b013e31827c5a5b. Review.

PMID:
23324974
22.

Chlamydia trachomatis infection may increase the risk of preeclampsia.

Haggerty CL, Panum I, Uldum SA, Bass DC, Olsen J, Darville T, Eastman JM, Simhan HN, Roberts JM, Ness RB.

Pregnancy Hypertens. 2013 Jan;3(1):28-33. doi: 10.1016/j.preghy.2012.09.002. Epub 2012 Sep 28.

PMID:
26105737
23.

Racial variation in toll-like receptor variants among women with pelvic inflammatory disease.

Taylor BD, Darville T, Ferrell RE, Ness RB, Haggerty CL.

J Infect Dis. 2013 Mar 15;207(6):940-6. doi: 10.1093/infdis/jis922. Epub 2012 Dec 18.

24.

Newborns of preeclamptic women show evidence of sex-specific disparity in fetal growth.

Reynolds SA, Roberts JM, Bodnar LM, Haggerty CL, Youk AO, Catov JM.

Gend Med. 2012 Dec;9(6):424-35. doi: 10.1016/j.genm.2012.10.013.

PMID:
23217566
25.

Stimulating an immune response? Oral sex is associated with less endometritis.

Pittrof R, Sully E, Bass DC, Kelsey SF, Ness RB, Haggerty CL.

Int J STD AIDS. 2012 Nov;23(11):775-80. doi: 10.1258/ijsa.2012.011407.

26.

Second trimester anti-angiogenic proteins and preeclampsia.

Haggerty CL, Seifert ME, Tang G, Olsen J, Bass DC, Karumanchi SA, Ness RB.

Pregnancy Hypertens. 2012 Apr 1;2(2):158-163.

27.

Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease.

Taylor BD, Darville T, Ferrell RE, Kammerer CM, Ness RB, Haggerty CL.

J Infect Dis. 2012 Feb 15;205(4):603-9. doi: 10.1093/infdis/jir822. Epub 2012 Jan 11.

28.

Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease.

Haggerty CL, Taylor BD.

Infect Dis Obstet Gynecol. 2011;2011:959816. doi: 10.1155/2011/959816. Epub 2011 Dec 25. Review.

29.

The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory disease.

Taylor BD, Darville T, Tan C, Bavoil PM, Ness RB, Haggerty CL.

Infect Dis Obstet Gynecol. 2011;2011:989762. doi: 10.1155/2011/989762. Epub 2011 Oct 19.

30.

Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.

Taylor BD, Haggerty CL.

Infect Drug Resist. 2011;4:19-29. doi: 10.2147/IDR.S12715. Epub 2011 Jan 20.

31.

Adverse adolescent reproductive health outcomes after pelvic inflammatory disease.

Trent M, Haggerty CL, Jennings JM, Lee S, Bass DC, Ness R.

Arch Pediatr Adolesc Med. 2011 Jan;165(1):49-54. doi: 10.1001/archpediatrics.2010.256.

32.

Microbial correlates of delayed care for pelvic inflammatory disease.

Taylor BD, Ness RB, Darville T, Haggerty CL.

Sex Transm Dis. 2011 May;38(5):434-8. doi: 10.1097/OLQ.0b013e3181ffa7c7.

33.

Advance provision of emergency contraception among adolescent and young adult women: a systematic review of literature.

Meyer JL, Gold MA, Haggerty CL.

J Pediatr Adolesc Gynecol. 2011 Feb;24(1):2-9. doi: 10.1016/j.jpag.2010.06.002. Epub 2010 Sep 24. Review.

PMID:
20869281
34.

Risk of sequelae after Chlamydia trachomatis genital infection in women.

Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55. doi: 10.1086/652395. Review.

PMID:
20470050
35.

Mycoplasma genitalium among young, urban pregnant women.

Short VL, Jensen JS, Nelson DB, Murray PJ, Ness RB, Haggerty CL.

Infect Dis Obstet Gynecol. 2010;2010:984760. doi: 10.1155/2010/984760. Epub 2010 Mar 31.

36.

The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease.

Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, Murray P, Haggerty CL.

Sex Transm Infect. 2010 Feb;86(1):29-31. doi: 10.1136/sti.2009.037721. Epub 2009 Aug 24.

37.

Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family.

Tan C, Hsia RC, Shou H, Haggerty CL, Ness RB, Gaydos CA, Dean D, Scurlock AM, Wilson DP, Bavoil PM.

Infect Immun. 2009 Aug;77(8):3218-26. doi: 10.1128/IAI.01566-08. Epub 2009 Jun 1.

38.

Diagnosis and treatment of pelvic inflammatory disease.

Haggerty CL, Ness RB.

Womens Health (Lond). 2008 Jul;4(4):383-97. doi: 10.2217/17455057.4.4.383. Review.

PMID:
19072503
39.

Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease.

Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, Haggerty CL.

Clin Infect Dis. 2009 Jan 1;48(1):41-7. doi: 10.1086/594123.

40.

Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria.

Haggerty CL, Totten PA, Ferris M, Martin DH, Hoferka S, Astete SG, Ondondo R, Norori J, Ness RB.

Sex Transm Infect. 2009 Aug;85(4):242-8. doi: 10.1136/sti.2008.032821. Epub 2008 Nov 12.

41.

Preeclampsia and risk for epilepsy in offspring.

Wu CS, Sun Y, Vestergaard M, Christensen J, Ness RB, Haggerty CL, Olsen J.

Pediatrics. 2008 Nov;122(5):1072-8. doi: 10.1542/peds.2007-3666.

PMID:
18977989
42.

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

Haggerty CL, Totten PA, Astete SG, Lee S, Hoferka SL, Kelsey SF, Ness RB.

Sex Transm Infect. 2008 Oct;84(5):338-42. doi: 10.1136/sti.2008.030486. Epub 2008 Apr 29.

43.

Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease.

Haggerty CL.

Curr Opin Infect Dis. 2008 Feb;21(1):65-9. doi: 10.1097/QCO.0b013e3282f3d9ac. Review.

PMID:
18192788
44.

Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.

Haggerty CL, Totten PA, Astete SG, Ness RB.

Infect Dis Obstet Gynecol. 2006;2006:30184.

45.

Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population.

Hegewald MJ, Lefor MJ, Jensen RL, Crapo RO, Kritchevsky SB, Haggerty CL, Bauer DC, Satterfield S, Harris T.

Chest. 2007 May;131(5):1494-9. Epub 2007 Mar 30.

PMID:
17400677
46.

Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.

Haggerty CL, Ness RB.

Clin Infect Dis. 2007 Apr 1;44(7):953-60. Epub 2007 Feb 15. Review.

PMID:
17342647
47.

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.

Haggerty CL, Ness RB.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):235-47. Review.

PMID:
16597205
48.

Estrogen replacement, muscle composition, and physical function: The Health ABC Study.

Taaffe DR, Newman AB, Haggerty CL, Colbert LH, de Rekeneire N, Visser M, Goodpaster BH, Nevitt MC, Tylavsky FA, Harris TB.

Med Sci Sports Exerc. 2005 Oct;37(10):1741-7.

PMID:
16260975
49.

Association between allelic variants in cytokine genes and preeclampsia.

Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB.

Am J Obstet Gynecol. 2005 Jul;193(1):209-15.

PMID:
16021081
50.

Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease.

Haggerty CL, Peipert JF, Weitzen S, Hendrix SL, Holley RL, Nelson DB, Randall H, Soper DE, Wiesenfeld HC, Ness RB; PID Evaluation and Clinical Health (PEACH) Study Investigators.

Sex Transm Dis. 2005 May;32(5):293-9.

PMID:
15849530

Supplemental Content

Loading ...
Support Center